Total raised
—
Stage
Acquired
Founded
2003
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
KoVax develops and manufactures aquaculture vaccines for viral and bacterial diseases and provides diagnostic services for all stages of fish growth. KoVax produces and markets autogenous vaccines for bacterial diseases, including the patented CyHV3 (KHV) vaccine and KV3 for koi and common carp. KV3 is a patent that KoVax acquired from the Hebrew University and the Israeli Ministry of Agriculture. The company has also developed a vaccine against TLV (TiLV).
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Agriculture & FoodMarine LifeFish
Business model
B2B
Highlights
1 PatentsVerified
Tags
aquaculturepharmaceuticalsveterinarybiotechnologyagtechfish-farmslivestockdisease-managementvaccines